制药公司向日本专业医学协会执行委员会成员支付款项。
Pharmaceutical Company Payments to Executive Board Members of Professional Medical Associations in Japan.
机构信息
Department of Gastroenterology, Sendai Kousei Hospital, Sendai, Miyagi, Japan.
Medical Governance Research Institute, Minato-ku, Tokyo, Japan.
出版信息
JAMA Intern Med. 2019 Apr 1;179(4):578-580. doi: 10.1001/jamainternmed.2018.7283.
Abstract
This analysis of data from pharmaceutical manufacturers assesses the extent and distribution of industry payments to the executive board members of professional medical associations in Japan.
摘要
本分析报告对制药商的数据进行了评估，以评估日本专业医疗协会的执行委员会成员所收到的行业支付的程度和分布情况。
相似文献
1
Pharmaceutical Company Payments to Executive Board Members of Professional Medical Associations in Japan.制药公司向日本专业医学协会执行委员会成员支付款项。
JAMA Intern Med. 2019 Apr 1;179(4):578-580. doi: 10.1001/jamainternmed.2018.7283.
2
Financial Relationships With Industry of Editorial Board Members of the Three Journals of the American Society for Radiation Oncology.美国放射肿瘤学会三本期刊编辑委员会成员与行业的财务关系。
Int J Radiat Oncol Biol Phys. 2017 Oct 1;99(2):286-291. doi: 10.1016/j.ijrobp.2017.03.020. Epub 2017 Mar 18.
3
Health care salaries across industry sectors: uncovering compensation differences.各行业部门的医疗保健薪资：揭示薪酬差异。
Caring. 2004 Mar;23(3):28-32.
4
Local pay. Performing rights.本地薪酬。表演权。
Health Serv J. 1997 Apr 10;107(5548):33.
5
OR managers' raises take dip but compare well.运营经理的薪资涨幅虽有所下降，但仍具可比性。
OR Manager. 1996 Oct;12(10):1, 12-16.
6
How do your staff salaries stack up?你们员工的薪资水平相比如何？
Med Econ. 2003 Apr 11;80(7):32-4, 39.
7
8
9
Payday! Trade associations are paying their top executives more than ever.发薪日！行业协会支付给其高管的薪酬比以往任何时候都高。
Natl J (Wash). 1994 Dec 17;26(51-52):2948-61.
引用本文的文献
1
Pharmaceutical Industry Payments to Professional Medical Societies in Japan.日本制药行业向专业医学协会的付款。
J Gen Intern Med. 2024 Jun;39(8):1534-1535. doi: 10.1007/s11606-024-08735-5. Epub 2024 Mar 22.
2
Association between Conflicts of Interest Disclosure and Quality of Clinical Practice Guidelines in Japan: A Meta-Epidemiological Study.日本利益冲突披露与临床实践指南质量之间的关联：一项元流行病学研究。
J Pers Med. 2023 Dec 17;13(12):1722. doi: 10.3390/jpm13121722.
3
Assessment of Financial Relationships Between Otorhinolaryngologists and Pharmaceutical Companies in Japan Between 2016 and 2019.2016年至2019年日本耳鼻喉科医生与制药公司之间财务关系的评估
Cureus. 2023 Aug 17;15(8):e43633. doi: 10.7759/cureus.43633. eCollection 2023 Aug.
4
Pharmaceutical payments to Japanese board-certified dermatologists: a 4-year retrospective analysis of personal payments from pharmaceutical companies between 2016 and 2019.药企向日本皮肤科专家支付薪酬情况：2016 年至 2019 年药企对个人薪酬的 4 年回溯性分析。
Sci Rep. 2023 May 8;13(1):7425. doi: 10.1038/s41598-023-34705-8.
5
Cross-sectional analysis of pharmaceutical payments to Japanese board-certified gastroenterologists between 2016 and 2019.2016 年至 2019 年日本肠胃病学委员会认证医师收到的药品付款的横断面分析。
BMJ Open. 2023 Apr 18;13(4):e068237. doi: 10.1136/bmjopen-2022-068237.
6
Pharmaceutical Payments to Japanese Board-Certified Head and Neck Surgeons Between 2016 and 2019.2016年至2019年间制药公司向日本头颈外科专科医生的付款情况。
OTO Open. 2023 Feb 17;7(1):e31. doi: 10.1002/oto2.31. eCollection 2023 Jan-Mar.
7
International comparison of pharmaceutical industry payment disclosures in the UK and Japan: implications for self-regulation, public regulation, and transparency.英国和日本制药行业支付披露的国际比较：对自我监管、公共监管和透明度的影响。
Global Health. 2023 Mar 3;19(1):14. doi: 10.1186/s12992-022-00902-9.
8
Evaluation of non-research payments from pharmaceutical companies to urologists in Japan between 2016 and 2019.评估 2016 年至 2019 年期间日本泌尿科医生从制药公司获得的非研究款项。
Int Urogynecol J. 2023 Jun;34(6):1285-1292. doi: 10.1007/s00192-023-05463-y. Epub 2023 Feb 1.
9
Pharmaceutical Payments to Japanese Board-Certified Infectious Disease Specialists: A Four-Year Retrospective Analysis of Payments from 92 Pharmaceutical Companies between 2016 and 2019.医药企业向日本传染病专家支付情况：92 家药企 2016-2019 年四年间支付情况回顾性分析。
Int J Environ Res Public Health. 2022 Jun 16;19(12):7417. doi: 10.3390/ijerph19127417.
10
Awareness and Perceptions among Members of a Japanese Cancer Patient Advocacy Group Concerning the Financial Relationships between the Pharmaceutical Industry and Physicians.日本癌症患者权益倡导团体成员对制药行业与医生之间财务关系的认知和看法。
Int J Environ Res Public Health. 2022 Mar 15;19(6):3478. doi: 10.3390/ijerph19063478.
本文引用的文献
1
Types and Distribution of Payments From Industry to Physicians in 2015.2015年行业向医生支付款项的类型及分布情况。
JAMA. 2017 May 2;317(17):1774-1784. doi: 10.1001/jama.2017.3091.
2
Conflict of interest between professional medical societies and industry: a cross-sectional study of Italian medical societies' websites.专业医学协会与行业之间的利益冲突：对意大利医学协会网站的横断面研究。
BMJ Open. 2016 Jun 1;6(6):e011124. doi: 10.1136/bmjopen-2016-011124.
3
Professional medical associations and their relationships with industry: a proposal for controlling conflict of interest.专业医学协会及其与行业的关系：关于控制利益冲突的提议。
JAMA. 2009 Apr 1;301(13):1367-72. doi: 10.1001/jama.2009.407.
Zotero 插件